GFAP and Alzheimer disease: Plasma levels of protein biomarkers glial fibrillary acidic protein (GFAP) and neurofilament light (NEFL) are key dementia biomarkers, but it is unclear how risk genes for Alzheimer’s disease (AD) influence levels of these biomarkers.